«
»

News and press releases: European Medicines Agency releases guideline on medicinal products for the treatment of schizophrenia

The European Medicines Agency has updated its guidance for pharmaceutical companies developing medicinal products for the treatment of schizophrenia.
Go to Source

Share and Enjoy:
  • Add to favorites
  • email
  • Print
  • Twitter
  • Facebook
  • Digg
  • StumbleUpon
  • del.icio.us
  • Yahoo! Buzz
  • Google Bookmarks
  • Google Buzz
  • FriendFeed
  • LinkedIn
  • Live
  • Posterous
  • Reddit
  • Technorati
  • Wikio


This entry was posted on Saturday, October 13th, 2012 at 11:30 pm and is filed under European Medicines Agency. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.

Comments are closed.

Leave a Reply

You must be logged in to post a comment.

MySQL query error